000			01344 a2200373 4500
005			20250514155054.0
264		0	_c20031110
008			200311s 0 0 eng d
022			_a1524-4628
024	7		_a10.1161/01.STR.0000094580.14898.7C _2doi
040			_aNLM _beng _cNLM
100	1		_aBonelli, Raphael M
245	0	0	_aEditorial comment--How to treat vascular dementia? _h[electronic resource]
260			_bStroke _cOct 2003
300			_a2331-2 p. _bdigital
500			_aPublication Type: Editorial; Comment
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aCholinesterase Inhibitors _xtherapeutic use
650	0	4	_aClinical Trials as Topic _xstatistics & numerical data
650	0	4	_aDementia, Vascular _xdrug therapy
650	0	4	_aDonepezil
650	0	4	_aGalantamine _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIndans _xtherapeutic use
650	0	4	_aMemantine _xtherapeutic use
650	0	4	_aNootropic Agents _xtherapeutic use
650	0	4	_aPhenylcarbamates
650	0	4	_aPiperidines _xtherapeutic use
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aRivastigmine
650	0	4	_aTreatment Outcome
773	0		_tStroke _gvol. 34 _gno. 10 _gp. 2331-2
856	4	0	_uhttps://doi.org/10.1161/01.STR.0000094580.14898.7C _zAvailable from publisher's website
999			_c14262275 _d14262275